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Current data are released electronically on Internet system, and metabolic diseases for human use
for all individual surveys as they become avail- totaled $25.6 billion, a 7.6-percent increase from
able.  Use: http://www.census.gov/mcd/. $23.8 billion in 2005; pharmaceutical prepara-
Individual reports can be accessed by choosing tions acting on the central nervous system and
"Current Industrial Reports (CIR)," clicking on sense organs for human use totaled $29.9 billion,
"CIRs by Subsector;" then choose the survey of a 16.5 percent increase from $25.6 billion in 
interest.  Follow the menu to view the PDF file 2005; pharmaceutical preparations acting on the 
or to download the worksheet file (XLS format) cardiovascular system for human use totaled
to your personal computer. $10.9 billion, a 6.5 percent increase from $10.2 
billion in 2005; pharmaceutical preparations 
These data are also available on Internet acting on the respiratory system for human use
through the U.S. Department of Commerce totaled $18.5 billion, a 13.1-percent increase from  
and STAT-USA by subscription.  The Internet $16.4 billion in 2005; pharmaceutical preparations
address is:  www.stat-usa.gov/.  Follow the acting on the digestive or genito-urinary system
prompts to register.  Also, you may call for human use totaled $15.4 billion, an 8.8-per-
202-482-1986 or 1-800-STAT-USA, for cent decrease from $16.8 billion in 2005; pharma-
further information. ceutical preparations acting on the skin for human
use totaled $3.7 billion, virtually unchanged from
SUMMARY OF FINDINGS 2005; vitamin, nutrient, and hematinic prepara-
tions for human use totaled $7.8 billion, a 2.6-per-
The total value of shipments for pharmaceutical cent increase from $7.6 billion in 2005; pharma-
preparations in the United States totaled $127.1 ceutical preparations affecting parasitic and
billion in 2006, a 7.2-percent increase from $118.6 infective diseases for human use totaled $11.7
billion in 2005.  The leading product category billion, a 3.8-percent increase from $11.2 billion
was pharmaceutical preparations acting on the in 2005; and pharmaceutical preparations for
central nervous system and sense organs for veterinary use totaled $3.8 billion, a 12.9-percent
human use, which increased 16.5 percent to increase from $3.4 billion in 2005.
$29.9 billion in 2006, from $25.6 billion in 2005.
For general CIR information, explanation of
The value of shipments for individual product general terms and historical note, see the
categories in 2006 were:  pharmaceutical appendix.
preparations affecting neoplasm, endocrine
Address inquiries concerning these data to Primary Goods Industries Branch, Manufacturing and Construction Division, (MCD), Washington, DC 20233-6900,
or call Michael Reich, 301-763-5163.
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Table 1.  Value of Product Class Shipments of Pharmaceutical Preparations, Except Biologicals:  2002 to 2006
[Value in thousands of dollars]     
Product
code Product description 2006 2005 2004 2003 2002
Pharmaceutical preparations................... 127,141,816 118,647,404 109,851,975 107,561,388 100,741,449
3254121100     Pharmaceutical preparations 
      affecting neoplasms, endocrine
      system, and metabolic diseases,
      for human use.................................... 25,577,203 23,779,261 20,789,103 20,064,796 17,499,148
3254124100     Pharmaceutical preparations 
      acting on the central nervous 
      system and sense organs, for
      human use......................................... 29,857,767 25,627,446 25,001,154 24,759,304 24,344,732
3254127100     Pharmaceutical preparations 
      acting on the cardiovascular 
      system, for human use...................... 10,901,093 10,232,377 10,223,797 9,670,724 10,338,754
325412A100     Pharmaceutical preparations 
      acting on the respiratory 
      system, for human use...................... 18,516,268 16,367,218 15,148,446 13,757,675 12,504,287
325412D100     Pharmaceutical preparations 
      acting on the digestive or
     genito-urinary system,
      for human use.................................... 15,354,493 16,828,648 15,251,818 15,051,690 13,373,247
325412G100     Pharmaceutical preparations
      acting on the skin, for human
      use...................................................... 3,719,087 r/  3,656,687 3,283,003 3,082,863 2,844,436
325412L100     Vitamin, nutrient, and 
      hematinic preparations, 
      for human use.................................... 7,754,511 r/  7,555,845 6,683,224 6,876,680 6,028,849
325412P100     Pharmaceutical preparations 
      affecting parasitic and
      ineffective diseases, for
      human use......................................... 11,654,118 11,228,479 10,818,532 11,848,410 11,336,918
325412T100     Pharmaceutical preparations
      for veterinary use.............................. 3,807,276 3,371,443 2,652,898 2,449,246 2,471,078
      r/Revised 5 percent or more from previously publised data.
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325412 Pharmaceutical preparations
  (except biologicals)...............................  127,141,816 107,236,274 16,529,983 3,375,559 118,647,404 99,329,466 r/ 14,908,998 4,408,940
3254121     Pharmaceutical preparations 
      affecting neoplasms,
      endocrine system, and
      metabolic diseases,
      for human use...................................  25,577,203 (D) (D) (D) 23,779,261 (D) (D) (D)
        Hormones and synthetic
          substitutes:   
3254121114             Corticoids, systemic, local,
              and topical, including anit-
              infective combinations.............  2,040,524 2,030,818 b/ 9,706 (D) 1,057,296 a/ 1,048,310 8,986 (D)
3254121121             Androgens................................... a/ 100,089 a/ 100,089 (X) (D) b/r/ 95,087 b/r/ 95,087 (X) (D)
3254121126             Estrogens.................................... c/ 725,844 c/ 725,844 (X) - 636,397 636,397 (X) -
3254121131             Insulin and antidiabetic 
              agents.......................................  2,171,265 2,171,265 (X) (D) 1,666,983 1,666,983 (X) (D)
3254121141             Oral contraceptive 
              preparations............................. c/ 815,503 c/ 815,503 (X) - r/ 753,638 r/ 753,638 (X) -
3254121146             Progestogens (excluding  
              premenstrual tension
              preparations, see 
              code 325412D196).................... a/ 209,130 a/ 209,130 (X) (D) r/ 248,791 r/ 248,791 (X) (D)
3254121156             Thyroid and antithyroid
              preparations, including
              iodides......................................  821,419 821,419 (X) - a/ 891,449 a/ 891,449 (X) -
3254121161             Anabolic agents...........................  29,127 29,127 (X) - r/ 29,246 r/ 29,246 (X) -
3254121165             Other hormone preparations
              including sex hormone
              combinations, and ACTH..........  989,147 (D) (D) - r/ 1,005,468 (D) (D) -
3254121177         Antineoplastic agents, including 
          radioactive isotopes and  
          specific antineoplastic agents......  2,709,515 2,709,515 (X) (D) a/ 3,244,181 a/ 3,244,181 (X) (D)
3254121181         Other pharmaceutical 
          preparations affecting
          neoplasms, the endocrine  
          system, and metabolic,  
          for human use...............................  13,687,788 (D) (D) (D) 12,616,597 (D) (D) (D)
3254124     Pharmaceutical preparations 
      acting on the central
      nervous system and the
      sense organs, for human
      use....................................................  29,857,767 26,718,749 2,750,495 b/ 388,523 25,627,446 22,238,800 2,249,629 r/ 1,139,017
3254124111         Parasympathomimetic 
          cholinergic drugs.......................... c/ 25,418 c/ 25,418 (X) (D) c/ 16,302 c/ 16,302 (X) (D)
3254124114         Skeletal muscle relaxants................ a/ 388,940 (D) (D) - 406,069 (D) (D) (D)
        Internal analgesics and 
          antipyretics:
           Narcotic:
3254124117                Opium and derivatives............  496,534 496,534 (X) - r/ 562,662 r/ 562,662 (X) -
3254124121                Synthetic narcotics.................. c/ 1,148,759 c/ 1,148,759 (X) (D) 1,098,368 1,098,368 (X) (D)
           Nonnarcotic:
3254124122                Salicylates, including aspirin
                 (acetylsalicylic acid) and
                 others such as sodium
                 salicylate................................ b/ 387,708 (D) (D) (D) b/ 409,547 (D) (D) (D)
3254124131                Aspirin combinations...............  118,544 (D) (D) - 147,857 (D) (D) -
3254124134                Acetaminophen and 
                 combinations.........................  750,750 b/ 67,868 682,882 c/ 13,544 517,951 b/r/ 66,304 451,647 12,717
3254124137                Antiarthritics (non-
                 hormonal).............................. a/ 801,094 277,729 523,365 b/ 118,450 a/ 699,615 319,718 379,897 b/ 108,312
3254124141         Other internal analgesics 
          and antipyretics, includ-
          ing effervescent types 
          and suppositories.........................  134,142 (D) (D) - 61,673 (D) (D) (D)
3254124144         Anticonvulsants, excluding
          phenobarbital...............................  2,775,639 2,775,639 (X) 24,909 c/ 2,095,086 c/ 2,095,086 (X) 23,470
        Psycotherapeutic agents:
3254124147            Antidepressants...........................  6,585,546 6,585,546 (X) 29,678 a/ 5,320,728 a/ 5,320,728 (X) (D)
           Tranquilizers:
3254124151                 Phenothiazine derivatives......  114,696 114,696 (X) - 92,407 92,407 (X) -
3254124154                 Other tranquilizers................. c/ 16,023 c/ 16,023 (X) - r/ 32,179 r/ 32,179 (X) -
3254124157            Other psychotherapeutic 
             agents........................................  6,600,929 6,600,929 (X) (D) r/ 5,246,855 r/ 5,246,855 (X) -
3254124165         Central nervous system stimu-
          lants (respiratory and cere-
          bral stimulants, including 
          sympathomimetic agents em-
          ployed mainly as CNS stimu-
          lants); excluding nondrug 
          dietaries for weight 
          control)......................................... c/ 1,445,545 c/ 1,445,545 (X) (D) 1,459,828 1,459,828 (X) 21,479
        Sedatives and hypnotics:
            Prescription:
3254124171                 Barbiturates............................ b/ 18,072 b/ 18,072 (X) (D) r/ 16,097 r/ 16,097 (X) (D)
3254124174                 Nonbarbiturates...................... b/ 293,755 b/ 293,755 (X) (D) b/ 257,029 b/ 257,029 (X) (D)
3254124178             Nonprescription, sleep induc-
              ers, and calming agents............  73,021 (X) 73,021 - 55,100 (X) 55,100 -
3254124189         Anesthetics including general,
          local, and topical (excluding
          urinary tract anesthetics 
          and skin preparations used 
          as antipruritics)............................ a/ 817,184 a/ 801,011 16,173 (D) 720,246 700,276 r/ 19,970 (D)
        Eye and ear preparations, 
          excluding anti-infectives, 
          corticoids and antibacter-
          ials and antiseptics:
3254124193             Contact lens solutions................  597,456 - 597,456 (D) 574,614 - 574,614 (D)
3254124196             Other eye and ear prepara-
              tions, including mydriatics, 
              and miotics...............................  1,933,052 (D) (D) - 1,708,941 (D) (D) (D)
3254124197         Other pharmaceutical prepara-
          tions acting on the central 
          nervous system and the 
          sense organs for human use.........  3,946,437 3,783,052 b/ 163,385 b/ 126,062 r/ 2,989,275 2,858,014 b/ 131,261 (D)
3254127     Pharmaceutical preparations 
      acting on the cardiovascular 
      system, for human use.....................  10,901,093 (D) (D) 115,569 10,232,377 (D) (D) r/ 121,520
2006 2005
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3254127118         Anticoagulants, hemostatics,
          and digitalis preparations.............  1,559,905 (D) (D) (D) 1,332,426 (D) (D) (D)
3254127128         Hypotensives including rauwolfia-
          alkaloid preparations and beta
          receptor blocking agents..............  (D) (D) (D) (D) (D) (D) (D) (D)
        Vasodilators:
3254127143             Coronary and peripheral.............  (D) (D) - - (D) (D) - -
3254127151             Antiarrythmics, such
              as propanolol and
              quinidine...................................  61,049 61,049 (X) (D) a/r/ 83,716 a/r/ 83,716 (X) (D)
3254127156             Calcium channel blockers 
              such as isoptin, calan, 
              procardia, cardizem,
              adalat........................................ a/ 624,150 a/ 624,150 (X) (D) r/ 467,310 r/ 467,310 (X) (D)
3254127161             Ace inhibitors, such as 
              vasotec, capoten,
              prinivil, and zestril...................  613,090 613,090 (X) (D) b/r/ 765,193 b/r/ 765,193 (X) -
3254127166         Other pharmaceutical prep-
          arations, acting on the 
          cardiovascular system 
          including vasopressors, 
          and antiheparin agents 
          for, human use..............................  5,869,439 (D) (D) 51,648 5,537,159 (D) (D) 39,203
325412A     Pharmaceutical preparations 
      acting on the respiratory 
      system, for human use..................... a/ 18,516,268 16,078,341 2,288,301 c/ 149,626 16,367,218 13,981,182 2,221,232 164,804
325412A113         Antihistamines (excluding cold
          preparations and antiemetics)
          and bronchial dilators,
          including antiasthmatics..............  8,792,890 (D) (D) (D) r/ 8,625,557 (D) (D) (D)
        Cough and cold preparations 
          (prescription) :
            Cough preparations and 
              expectorants (contain-
              ing antitussive or
              other ingredients
              intended primarily to
              treat cough only):
325412A123                 Narcotic and nonnarcotic.......  257,663 257,663 (X) (D) r/ 208,599 r/ 208,599 (X) (D)
            Cold preparations con-
              taining combinations of
              the following ingredi-
              ents, (but not antitus-  
              sive) nasal deconges-
              tant, antihistamine, 
              analgesic, bioflava-
              noid, or antibiotic):   
325412A136                 Antihistamine cold
                  preparations.........................  13,058 13,058 (X) - b/ 17,053 b/ 17,053 (X) -
325412A143                 Other prescription
                  cold prepartations,
                  including nasal
                  decongestants.......................  (D) (D) (X) - (D) (D) (X) (D)
325412A146             Cough and cold combina-  
              tions (prescription)................... a/ 61,857 a/ 61,857 (X) (D) 69,845 69,845 (X) (D)
            Cough and cold preparations 
              (nonprescription):
325412A153                 Decongestants, including
                  nasal sprays, and nose 
                  drops.....................................  234,240 (X) 234,240 (D) 237,264 (X) 237,264 (D)
325412A166                 Cough syrups..........................  717,021 (X) 717,021 - 652,765 (X) 652,765 -
325412A171                 Capsules and tablets...............  716,053 (X) 716,053 (D) r/ 673,999 (X) r/ 673,999 (D)
325412A176                 Lozenges.................................  16,129 (X) 16,129 - 18,473 (X) 18,473 -
325412A189                 Other nonprescription 
                  cough and cold prepara-
                  tions including topical and
                  cough drops..........................  (D) (X) (D) (D) (D) (X) (D) (D)
325412A196             Other pharmaceutical prep-
              arations acting on the 
              respiratory system
              including beta agonists,
              for human use...........................  7,423,621 7,414,511 9,110 (D) r/ 5,571,658 r/ 5,562,437 9,221 (D)
325412D     Pharmaceutical preparations    
      acting on the digestive or   
      the genito-urinary systems,
      for human use...................................  15,354,493 13,469,340 1,114,146 c/ 771,007 16,828,648 14,989,165 r/ 1,081,644 757,839
        Digestive system preparations: 
325412D111             Enzymes...................................... a/ 120,626 a/ 109,261 11,365 (D) 111,041 99,814 11,227 (D)
325412D115             Antacids, including acid 
              neutralizing products 
              with coating functions, 
              but excluding efferves-
              cent salicylate products
              classified as analgesics,
              and antidiarrheals.....................  1,823,760 1,203,674 a/ 620,086 (D) r/ 1,344,512 (D) (D) (D)
        Laxatives:
325412D121             Irritants.......................................  101,988 (D) (D) (D) 78,469 (D) (D) -
325412D123             Bulk producing and emollients...  (D) (D) (D) - (D) (D) (D) -
325412D127             Fecal softeners............................  92,816 (D) (D) (D) a/ 109,128 (D) (D) (D)
325412D134             Saline..........................................  (D) - (D) - (D) - (D) -
325412D137             Enema specialties.......................  62,647 (D) (D) - 57,933 (D) (D) -
        Antispasmodics and 
          anticholinergics:
325412D157             Synthetics...................................  4,425 4,425 (X) - 5,202 5,202 (X) -
325412D168             Other antispasmodics 
              and anticholinergics
              including ataractic combina-
              tions, belladonna and
              derivatives, and H2 blocking 
              agents.......................................  1,267,128 (D) (D) (D) 1,209,396 1,189,025 a/ 20,371 (D)
325412D175         Other digestive system prepara-
          tions, including emetics, diges-
          tants, bile therapy preparations
          antinauseants, motion sickness
          remedies, lipotropics,
          cholesterol reducers, and diet
          aids containing local
          anesthetics, for human use..........  9,340,011 9,327,556 12,455 (D) 11,183,150 11,172,882 r/ 10,268 (D)
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        Genito-urinary preparations:  
325412D177             Urinary antibacterials
              and antiseptics..........................  47,089 (D) (D) - 35,748 (D) (D) -
325412D182             Diuretics, thiazides and 
              related agents, excluding
              aminophylline, xan-
              thine, and rauwolfia-
              diuretic combinations.
              (see cardiovascular
              preparations)............................ b/ 165,637 (D) (D) (D) 142,422 (D) (D) (D)
325412D187             Oxytocics.................................... b/ 98,765 b/ 98,765 (X) - 89,399 89,399 (X) -
325412D195             Vaginal cleaners..........................  61,544 (D) (D) - 67,376 (D) (D) -
325412D196         Other pharmaceutical prep-
          arations acting on the 
          genito-urinary system, 
          including urinary tract
          anesthetics, contraceptive
          agents, and premenstrual
          tension preparations, for
          human use....................................  1,135,319 1,110,613 24,706 (D) 1,362,223 1,338,049 r/ 24,174 (D)
325412G     Pharmaceutical preparations 
      acting on the skin, for
      human use........................................  3,719,087 (D) 2,241,743 (D) a/r/ 3,656,687 (D) r/ 2,063,390 (D)
        Dermatological preparations:
325412G111             Emollients and protec-
              tives, including burn
              remedies and oint-
              ment bases................................  775,239 35,464 739,775 - 797,932 c/ 27,217 770,715 -
325412G116             Antipruritics and local  
               anesthetic skin
               preparations............................ a/ 209,421 134,012 b/ 75,409 - 183,520 132,412 51,108 (D)
325412G126              Antiacne preparations...............  554,948 (D) (D) (D) 569,426 342,249 227,177 (D)
325412G131              Antidandruff and anti-
               seborrheic prepara-
               tions (excluding dan-
               druff shampoos)......................  44,036 a/ 10,818 33,218 - 33,296 (D) (D) -
325412G138             Other dermatological prep-
               arations including coal
               tar, sulfur, and resorc-
               inol preparations.....................  568,167 374,592 193,575 (D) r/ 704,726 r/ 515,872 188,854 (D)
325412G141         Hemorrhoidal preparations............  76,225 (D) (D) - 81,192 (D) (D) -
325412G163         External analgesics and
          counterirritants including
          ointments, jellies, pastes, 
          creams, cerates, salves, 
          liquids, and rubbing alcohol.........  539,860 148,172 391,688 - 476,528 r/ 119,558 356,970 -
325412G166         Other pharmaceutical prep-
          arations acting on the
          skin, for human use...................... b/ 880,228 b/ 368,901 511,327 (D) b/r/ 739,934 c/ 351,656 a/r/ 388,278 (D)
325412L     Vitamin, nutrient, and hematinic 
      preparations, for human use............ a/ 7,754,511 a/ 1,877,370 a/ 5,575,178 b/ 301,963 r/ 7,555,845 r/ 2,099,313 r/ 5,190,972 b/ 265,560
        Vitamins:
325412L111            Multivitamins, plain and 
              with minerals, (excluding
              B complex vitamins
              and fish liver oils)..................... b/ 3,076,167 b/ 39,293 b/ 3,036,874 b/ 67,858 r/ 2,714,976 b/ 37,533 r/ 2,677,443 b/ 65,843
325412L116            Pediatric vitamin prep-
             arations (drops,
             suspensions and
             chewable tablets).......................  149,571 (D) (D) b/ 928 b/ 144,197 (D) (D) b/r/ 1,012
325412L121            Prenatal vitamin prep-
             arations......................................  120,534 (D) (D) (D) r/ 103,719 (D) (D) c/r/ 762
325412L126            B complex preparations...............  279,632 11,222 268,410 b/ 4,576 267,232 18,540 248,692 b/ 5,288
325412L135            All other vitamin preparations
              including fluoride
              preparations............................. a/ 704,160 b/ 46,783 a/ 657,377 b/ 91,205 r/ 726,924 41,662 r/ 685,262 c/ 67,745
325412L141         Fish liver oils (cod, etc.).................. a/ 185,254 (D) (D) a/ 496 138,549 (D) (D) a/ 230
325412L146         Nutrients, excluding thera-
          peutic dietary foods and
          infant formulas............................. b/ 302,220 92,780 b/ 209,440 a/ 106,696 322,830 69,734 253,096 a/ 92,929
325412L151         Tonics and alteratives..................... c/ 31,486 - c/ 31,486 - r/ 27,380 - r/ 27,380 -
        Hematinics:
325412L158             Oral and parenteral
              with B12.................................... c/ 30,726 (D) (D) (D) b/ 32,153 (D) (D) (D)
325412L168             Other oral and parenteral
              hematinics................................ a/ 64,658 (D) (D) (D) 65,125 (D) (D) (D)
325412L179         Other vitamin, nutrient,
          and hematinic prepara-
          tions including hopsital
          solutions but excluding bio-
          logicals such as blood
          plasma, for human use.................  2,508,140 a/ 1,463,398 1,044,742 b/ 25,815 r/ 2,747,200 r/ 1,723,729 r/ 1,023,471 28,942
325412P     Pharmaceutical preparations 
      affecting parasitic and infec-
      tive diseases, for human use............  11,654,118 10,040,394 1,489,548 124,176 b/ 11,228,479 a/ 9,822,350 1,234,312 171,817
       Anti-infective agents, ex-  
         cluding cortcoid anti-infec-
         tive combinations (see product 
         code 3254121015):  
325412P111            Amebicides and tricho-
             monicides..................................  37,828 37,828 - - 36,007 36,007 - -
325412P114            Anthelmintics...............................  (D) (D) (D) - 1,191 (D) (D) -
           Systemic antibiotic prep-  
             arations:
               Broad and medium spec-
                 trum (single or in combi-
                 nations with other anti-
                 biotics):
325412P117                    Tetracyclines, in-
                     cluding chlortet-
                     racycline and
                     congeners........................... c/ 317,073 c/ 317,073 (X) - 275,024 275,024 (X) -
325412P121                    Cephalosporins,
                     such as cefaman-
                     dolenafate and
                     cephalexin.......................... a/ 1,036,043 a/ 1,036,043 (X) (D) 1,204,157 1,204,157 (X) (D)
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325412P124                    Erythromycins, such
                     as erythromycin
                     ethylsuccinate and
                     erythromycin stearate.......  103,282 103,282 (X) - 107,862 107,862 (X) -
                   Penicillins (single):
                       Semisynthetic peni-
                         cillins, such as
                         amoxicillins,
                         and ampicillin:
325412P127                            Injectable.....................  (D) (D) (X) - 206,645 206,645 (X) -
325412P131                            Other forms.................  (D) (D) (X) - (D) (D) (X) -
325412P135                        Other penicillins, ex-
                         cluding semisynthetic,
                         such as penicillin V 
                         and penicillin G,
                         including injectable
                         and other forms.............  (D) (D) (X) - (D) (D) (X) -
325412P141                    Other broad and medium
                     spectrum antibiotics,
                     excluding sulfa-antibiotic
                     combinations.....................  621,246 (D) (D) - 761,658 (D) (D) -
325412P144                Antibiotics in combination
                 with sulfonamides................. b/ 15,541 b/ 15,541 (X) - r/ 13,804 r/ 13,804 (X) -
325412P147                Other systemic antibiotic 
                 preparations, including
                 narrow-spectrum anti-
                 biotics and streptomy-
                 cins........................................  (D) (D) (X) - (D) (D) (X) -
325412P151            Topical antibiotic preparations...  276,582 (D) (D) - r/ 367,415 (D) (D) -
325412P156            Tuberculostatic agents 
              including isoniazid (iso-
              nicotinic acid hydrazide), 
              and other antitubercular 
              preparations............................. b/ 29,518 b/ 29,518 - - b/r/ 21,903 b/r/ 21,903 - -
325412P161             Antimalarials (plasmodicides)....  29,287 29,287 (X) (D) a/r/ 36,246 a/r/ 36,246 (X) (D)
325412P164             Sulfonamides (excluding anti-
              biotic sulfonamide combi-
              nations).....................................  22,800 22,800 (X) - b/ 25,074 b/ 25,074 (X) -
325412P167             Antifungal preparations..............  1,074,170 932,580 141,590 - 1,233,812 1,057,129 176,683 -
325412P171             Antivirals, systemic,
              such as zovirax, and 
              retrovir......................................  5,001,668 (D) (D) 102,481 b/ 4,055,319 (D) (D) 78,273
325412P174             Other anti-infective agents.........  404,901 (D) (D) (D) (D) (D) (D) (D)
        Antibacterials and antiseptics:
325412P177             General........................................  247,382 (D) (D) 7,050 271,969 (D) (D) 7,192
325412P181             Mouth and throat preparations...  (D) 10,503 (D) (D) (D) 9,828 (D) (D)
325412P184         Other pharmaceutical prep-
          arations affecting parasitic
          and infective diseases, for
          human use....................................  367,148 349,426 17,722 (D) r/ 453,386 r/ 435,342 18,044 (D)
325412T     Pharmaceutical preparations for
      veterinary use...................................  3,807,276 2,580,241 1,051,155 175,880 3,371,443 2,333,697 r/ 853,624 r/ 184,122
325412T111        Anesthetics......................................  90,475 90,475 (X) - 60,795 60,795 (X) -
325412T116        Anthelmintics...................................  319,834 288,659 31,175 (D) 257,698 215,493 42,205 (D)
       Antibiotics:
325412T126            Penicillins....................................  38,133 20,839 17,294 - 39,131 26,947 12,184 -
325412T133            Other antibiotics including
              tetracyclines.............................  949,644 905,370 44,274 (D) 807,354 743,812 63,542 (D)
325412T136         Antiseptics, wound dress-  
          ings and fungicides.......................  66,368 (D) (D) - 80,550 (D) (D) (D)
325412T163         Hormones including insulin, 
           ACTH (corticotropin), and 
           other hormone preparations........  178,303 (D) (D) - 208,499 (D) (D) -
325412T171         Nitrofurans.....................................  (D) - (D) - (D) - (D) (D)
325412T176         Nutrients and tonics.......................  (D) (D) b/ 1,329 (D) (D) (D) r/ 1,377 (D)
325412T181         Parasiticides, external.....................  279,202 (D) (D) - r/ 161,601 (D) (D) (D)
325412T196         Other pharmaceutical prep-
          arations including vitamins,
          minerals, tranquilizers, ataractics,
          intravenous solutions,
          sulfonamides, electrolytes,
          hemostatics, and hematinics,
          for veterinary use.........................  1,701,294 990,098 711,196 (D) 1,563,653 1,065,510 a/r/ 498,143 (D)
      - Represents zero.     D  Withheld to avoid disclosing data for individual companies.      r/Revised 5 percent or more from previously published data.      X  Not applicable.    
      1/Data for "Bulk shipments" are excluded from all horizontal ten-digit product detail totals; however, these data are included in all seven-digit product class and six-digit industry
level totals.  Since bulk shipments are typically reported by a small number of producers, and often must be suppressed, inclusion of bulk shipments in all horizontal totals would require
the suppression of additional detail.
      Note:  Percent of estimation of each item is indicated as follows:  a/10 to 25 percent of this item is estimated.      b/25 to 50 percent of this item is estimated.     c/Over 50 percent of
this item is estimated. 
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Table 3.  Domestic Value of Shipments, Exports, Imports, and Apparent Consumption of Pharmaceutical Preparations, Except Biologicals:  2006 and 2005       
[Thousands of dollars]
Manu- Percent Percent
facturers' Exports of exports Imports for Apparent imports
Product Product description shipments domestic to manu- consump- consump- to apparent
code (value merchan- facturers' tion 2/ tion 3/ consumption
f.o.b. plant) dise 1/ shipments (value) (value) (value)
 
2006  
Pharmaceutical prepartions............................................................. 127,141,816 11,109,935 8.7 32,297,852 148,329,733 21.8
3254121100     Pharmaceutical preparations affecting neoplasms, endo-
      crine system, and metabolic diseases, for human use.............. 25,577,203 3,377,630 13.2 5,873,319 28,072,892 20.9
3254124100     Pharmaceutical preparations acting on the central nervous
      system and sense organs, for human use.................................. 29,857,767 2,092,310 7.0 5,349,795 33,115,252 16.2
3254127100     Pharmaceutical preparations acting on the cardiovascular
      system, for human use.............................................................. 10,901,093 1,752,681 16.1 11,785,087 20,933,499 56.3
325412A100     Pharmaceutical preparations acting on the respiratory
      system, for human use.............................................................. 18,516,268 608,742 3.3 2,269,224 20,176,750 11.2
325412D100     Pharmaceutical preparations acting on the digestive or
      genito-urinary system, for human use...................................... 15,354,493 250,057 1.6 2,120,339 17,224,775 12.3
325412G100     Pharmaceutical preparations acting on the skin, for human
      use.............................................................................................. 3,719,087 85,631 2.3 346,580 3,980,036 8.7
325412L100     Vitamin, nutrient, and hematinic preparations, for human
      use.............................................................................................. 7,754,511 336,515 4.3 248,060 7,666,056 3.2
325412P100     Pharmaceutical preparations affecting parasitic and
      infective diseases, for human use............................................. 11,654,118 2,349,545 20.2 3,736,216 13,040,789 28.7
325412T100     Pharmaceutical preparations for veterinary use......................... 3,807,276 256,824 6.7 569,232 4,119,684 13.8
2005
Pharmaceutical prepartions.............................................................  118,647,404 10,181,450 8.6 27,058,021 135,523,975 20.0
3254121100     Pharmaceutical preparations affecting neoplasms, endo-
      crine system, and metabolic diseases, for human use..............  23,779,261 2,898,772 12.2 4,986,873 25,867,362 19.3
3254124100     Pharmaceutical preparations acting on the central nervous
      system and sense organs, for human use..................................  25,627,446 2,217,027 8.7 4,643,207 28,053,626 16.6
3254127100     Pharmaceutical preparations acting on the cardiovascular
      system, for human use..............................................................  10,232,377 1,295,231 12.7 8,993,166 17,930,312 50.2
325412A100     Pharmaceutical preparations acting on the respiratory
      system, for human use..............................................................  16,367,218 458,486 2.8 1,743,603 17,652,335 9.9
325412D100     Pharmaceutical preparations acting on the digestive or
      genito-urinary system, for human use......................................  16,828,648 347,823 2.1 2,127,985 18,608,810 11.4
325412G100     Pharmaceutical preparations acting on the skin, for human
      use.............................................................................................. r/ 3,656,687 99,119 2.7 387,204 3,944,772 9.8
325412L100     Vitamin, nutrient, and hematinic preparations, for human
      use.............................................................................................. r/ 7,555,845 343,239 4.5 400,727 7,613,333 5.3
325412P100     Pharmaceutical preparations affecting parasitic and
      infective diseases, for human use.............................................  11,228,479 2,269,143 20.2 3,292,511 12,251,847 26.9
325412T100     Pharmaceutical preparations for veterinary use.........................  3,371,443 252,610 7.5 482,745 3,601,578 13.4
      1/Source:  Census Bureau report EM 545, U.S. Exports.
      2/Source:  Census Bureau report IM 145, U.S. Imports for Consumption.
      3/Apparent consumption represents new domestic supply and is derived by substracting exports from the total of manufacturers' shipments plus imports.
Table 4.  Comparison of North American Industry Classification (NAICS)-Based Product Codes with Schedule B Export Codes
               and HTSUSA Import Codes:  2006
Product
code Product description Export code 1/ Import code 2/
3254121100-- Pharmaceutical preparations affecting
  neoplasms, endocrine system, and
  metabolic disease........................................... 3003.31.0000, 3003.39.0000, 3003.31.0000, 3003.39.1000,
3003.40.0000, 3004.31.0000, 3003.39.5000, 3003.40.0000,
3004.32.0000, 3004.39.0050, 3004.31.0000, 3004.32.0000,
3004.90.9115 3004.39.0050, 3004.90.9115
3254124100-- Pharmaceutical preparations acting on
  central nervous system and sense
  organs............................................................. 3004.40.0020, 3004.40.0030, 3004.40.0020, 3004.40.0030,
3004.40.0040, 3004.90.9125, 3004.40.0040, 3004.90.9122,
3004.90.9130, 3004.90.9135, 3004.90.9126, 3004.90.9128,
3004.90.9140 3004.90.9130, 3004.90.9135,
3004.90.9140
3254127100-- Pharmaceutical preparations acting on 
  cardiovascular system.................................... 3004.40.0010, 3004.90.9120 3004.40.0010, 3004.90.9120
325412A100-- Pharmaceutical preparations acting on
  respiratory system......................................... 3004.40.0060, 3004.90.9175, 3004.40.0060, 3004.90.9175,
3004.90.9180, 3004.90.9185 3004.90.9180, 3004.90.9185
325412D100-- Pharmaceutical preparations acting on
  digestive or genitro-urinary system............... 3004.90.9150, 3004.90.9155, 3004.90.9150, 3004.90.9155,
3004.90.9160, 3004.90.9165, 3004.90.9160, 3004.90.9165,
3004.90.9170, 3006.60.0000 3004.90.9170, 3006.60.0000
325412G100-- Pharmaceutical preparations acting on
  skin................................................................. 3004.40.0050, 3004.90.9145 3004.40.0050, 3004.90.9145
325412L100-- Vitamin, nutrient and hematinic
  preparations................................................... 3004.50.4500, 3004.50.5010, 3004.50.1000, 3004.50.2000,
3004.50.5020, 3004.50.5030, 3004.50.3000, 3004.50.4000,
3004.50.5040 3004.50.5010, 3004.50.5020,
3004.50.5030, 3004.50.5040
325412P100-- Pharmaceutical preparations affecting
  parasitic and infective disease....................... 3003.10.0000, 3003.20.0000, 3003.10.0000, 3003.20.0000,
3004.10.1020, 3004.10.1045, 3004.10.1020, 3004.10.1045,
3004.10.5045, 3004.10.5060, 3004.10.5045, 3004.10.5060,
3004.20.0020, 3004.20.0030, 3004.20.0020, 3004.20.0030,
3004.20.0060, 3004.90.1000, 3004.20.0060, 3004.90.1000,
3004.90.9105, 3004.90.9110 3004.90.9105, 3004.90.9110
325412T100-- Pharmaceutical preparations for
  veterinary use................................................. 3004.10.1010, 3004.10.5010, 3004.10.1010, 3004.10.5010,
3004.20.0010, 3004.39.0010, 3004.20.0010, 3004.39.0010,
3004.40.0005, 3004.50.5005, 3004.40.0005, 3004.50.5005,
3004.90.9103 3004.90.9103
      1/Source:  2006 edition, Harmonized System-based Schedule B, Statistical Classification of Domestic and Foreign
Commodities Exported from the United States.    
      2/Source:  Harmonized tariff Schedule of the United States, Annotated (2006).
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Appendix.  
General CIR Survey Information, Explanation of General Terms
and Historical Note
GENERAL
The CIR program has been providing monthly,
quarterly, and annual measures of industrial activity for
many years. Since 1904, with its cotton and fats and oils
surveys, the CIR program has formed an essential part
of an integrated statistical system involving the quin-
quennial economic census, manufacturing sector, and
the annual survey of manufactures. The CIR surveys,
however, provide current statistics at a more detailed
product level than either of the other two statistical
programs.
The primary objective of the CIR program is to
produce timely, accurate data on production and
shipments of selected products. The data are used to
satisfy economic policy needs and for market analysis,
forecasting, and decision making in the private sector.
The product-level data generated by these surveys are
used extensively by individual firms, trade associations,
and market analysts in planning or recommending
marketing and legislative strategies, particularly if their
industry is significantly affected by foreign trade.
Although production and shipments information are the
two most common data items collected, the CIR
program collects other measures also such as
inventories, orders, and consumption. These surveys
measure manufacturing activity in important commodity
areas such as textiles and apparel, chemicals, primary
metals, computer and electronic components, industrial
equipment, aerospace equipment, and consumer
goods.
The CIR program uses a unified data collection,
processing, and publication system. The U.S. Census
Bureau updates the survey panels for most reports
annually and reconciles the estimates to the results of
the broader-based annual survey of manufactures and
the economic census, manufacturing sector. The manu-
facturing sector provides a complete list of all
producers of the products covered by the CIR program
and serves as the primary source for CIR sampling.
Where a small number of producers exist, CIR surveys
cover all known producers of a product. However, when
the number of producers is too large, cutoff and
random sampling techniques are used. Surveys are
continually reviewed and modified to provide the most
up-to-date information on products produced. The CIR
program includes a group of mandatory and voluntary
surveys.  Typically the monthly and quarterly surveys are
conducted on a voluntary basis. Those companies that
choose not to respond to the voluntary surveys are
required to submit a mandatory annual counterpart
corresponding to the more frequent survey.
NORTH AMERICAN INDUSTRY CLASSIFICATION
SYSTEM (NAICS), 1997 
The adoption of the North American Industry
Classification System (NAICS) in the 1997 Economic
Census has had a major impact on the comparability of
current and historic data. Approximately half of the
industries in the manufacturing sector of NAICS do not
have comparable industries in the Standard Industrial
Classification (SIC) system that was used in the past.
While most of the change affecting the
manufacturing sector was change within the sector,
some industries left manufacturing and others came into
manufacturing. Prominent among those that left
manufacturing are logging and portions of publishing.
Prominent among the industries that came into the
manufacturing sector are bakeries, candy stores where
candy is made on the premises, custom tailors, makers
of custom draperies, and tire retreading. The net effect
of the classification changes are such that if the 1997
value of shipments data for all manufacturers were
tabulated on an SIC basis, it would be approximately 3
percent higher.







48-49 Transportation and Warehousing
51 Information
52 Finance and Insurance
53 Real Estate and Rental and Leasing
54 Professional, Scientific, and Technical Services
55 Management of Companies and Enterprises
56 Administrative and Support and Waste Management
and Remediation Services
61 Educational Services
62 Health Care and Social Assistance
71 Arts, Entertainment, and Recreation
72 Accommodation and Food Services
81 Other Services (except Public Administration)
(Not listed above are the Agriculture, Forestry,
Fishing, and Hunting sector (NAICS 11), partially covered
by the census of agriculture conducted by the U.S.
Department of Agriculture, and the Public
Administration sector (NAICS 92), covered by the census
of governments conducted by the Census Bureau.)
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The 20 NAICS sectors are subdivided into 96
subsectors (three-digit codes), 313 industry groups
(four-digit codes), and, as implemented in the United
States, 1170 industries (five- and six-digit codes).
FUNDING
The Census Bureau funds most of the surveys.
However, a number of surveys are paid for either fully
or partially by other Federal Government agencies or
private trade associations. A few surveys are mandated,
but all are authorized by Title 13 of the United States
Code.
RELIABILITY OF DATA
Survey error may result from several sources
including the inability to obtain information about all
cases in the survey, response errors, definitional
difficulties, differences in the interpretation of
questions, mistakes in recording or coding the reported
data, and other errors of collection, response,
coverage, and estimation. These nonsampling errors
also occur in complete censuses. Although no direct
measurement of the biases due to these nonsampling
errors has been obtained, precautionary steps were
taken in all phases of the collection, processing, and
tabulation of the data in an effort to minimize their
influence.
A major source of bias in the published estimates is
the imputing of data for nonrespondents, for late
reporters, and for data that fail logic edits. Missing
figures are imputed based on period-to-period
movements shown by reporting firms. A figure is
considered to be an impute if the value was not directly
reported on the questionnaire, directly derived from
other reported items, directly available from
supplemental sources, or obtained from the respondent
during the analytical review phase. Imputation generally
is limited to a maximum of 10 percent for any one data
cell. Figures with imputation rates greater than 10
percent are suppressed or footnoted. The imputation
rate is not an explicit indicator of the potential error in
published figures due to nonresponse, because the
actual yearly movements for nonrespondents may or
may not closely agree with the imputed movements.
The range of difference between the actual and
imputed figures is assumed to be small. The degree of
uncertainty regarding the accuracy of the published
data increases as the percentage of imputation
increases. Figures with imputation rates above 10
percent should be used with caution.
DATA REVISIONS
Statistics for previous years may be revised as the
result of corrected figures from respondents, late
reports for which imputations were originally made, or
other corrections. Data that have been revised by more
than 5 percent from previously published data are
indicated by footnotes.
DISCLOSURE
The Census Bureau collects the CIR data under the
authority of Title 13, United States Code, which
specifies that the information can only be used for
statistical purposes and cannot be published or released
in any manner that would identify a person, household,
or establishment.  "D" indicates that data in the cell have
been suppressed to avoid disclosure of information
pertaining to individual companies.
EXPLANATION OF GENERAL TERMS
Capacity. The maximum quantity of a product that can
be produced in a plant in 1 day if operating for 24
hours. Includes the capacity of idle plants until the plant
is reported to be destroyed, dismantled, or abandoned.
Consumption.  Materials used in producing or
processing a product or otherwise removing the
product from the inventory.
Exports.  Includes all types of products shipped to
foreign countries, or to agents or exporters for
reshipment to foreign countries.
Gross shipments. The quantity or value of physical
shipments from domestic establishments of all products
sold, transferred to other establishments of the same
company, or shipped on consignment, whether for
domestic or export sale or use. Shipments of products
purchased for resale are omitted. Shipments of
products made under toll arrangements are included.
Interplant transfers.  Shipments to other domestic
plants within a company for further assembly,
fabrication, or manufacture.
Inventories.  The quantity or value of finished goods,
work in progress, and materials on hand.
Machinery in place. The number of machines of a
particular type in place as of a particular date whether
the machinery was used for production, prototype, or
sampling, or was idle. Machinery in place includes all
machinery set up in operating positions.
Net receipts.  Derived by subtracting the materials held
at the end of the previous month from the sum of
materials used during the current month.
Production.  The total volume of products produced,
including: products sold; products transferred or added
to inventory after adjustments for breakage, shrinkage,
and obsolescence, plus any other inventory adjustment;
and products that undergo further manufacture at the
same establishment.  
Quantities produced and consumed. Quantities of
each type of product produced by a company for
internal consumption within that same company.
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Quantity and value of new orders.  The sales value
of orders received during the current reporting period
for products and services to be delivered immediately
or at some future date. Also represents the net sales
value of contract change documents that increase or
decrease the sales value of the orders to which they are 
related, when the parties concerned are in substantial
agreement as to the amount involved.  Included as
orders are only those that are supported by binding
legal documents such as signed contracts or letter
contracts.
Quantity and value of shipments.  The figures on
quantity and value of shipments represent physical
shipments of all products sold, transferred to other
establishments of the same company, or shipped on
consignment, whether for domestic or export sale. The
value represents the net sales price, f.o.b. plant, to the
customer or branch to which the products are shipped,
net of discounts, allowances, freight charges, and
returns. Shipments to a company's own branches are
assigned the same value as comparable appropriate
allocation of company overhead and profit. Products
bought and resold without further manufacture are
excluded.
Stocks. Total quantity of ending finished inventory.
Unfilled orders (backlog). Calculated by adding net
new orders and subtracting net sales from the backlog
at the end of the preceding year.
HISTORICAL NOTE
Data on pharmaceutical preparations, except
biologicals, have been collected by the Census Bureau
since 1962.  Historical data may be obtained from
Current Industrial Reports available at your local Federal
Depository Library.
